Migraine medicine recalled over concerns of infection
SOUTH BEND – The pharmaceutical company Pfizer is recalling some RELPAX medication over concerns that it may cause infections that are life-threatening.
The drug is used to treat severe headaches/migraines.
According to Pfizer, the medication contains Pseudomonas and Burkholderia – bacteria that could move from the gut to the bloodstream.
The information below is contained on the labels of the 4omg tablets that Pfizar is recalling:
Carton NDC | Lot | Expiration | Strength | Configuration/Count |
0049-2340-45 | AR5407 | 2022 FEB | 40 mg | Carton containing 6 tablets (1 blister card x 6 tablets) |
0049-2340-05 | CD4565 | 2022 FEB | 40 mg | Carton containing 12 tablets (2 blister cards x 6 tablets) |
So far there have not been any reports of issues with the medication, according to Pfizer.
Federal Drug Administration recommends that you call your doctor to determine if the medication is included in the recall.
Anyone who is in possession of the medication is encouraged to return to their pharmacist or call Stericycle Inc. at 877-225-9750.
For more information, visit the FDA’s website.
